Mon. May 25th, 2026
Spread the love

Carlos Alcaraz beat Jannik Sinner in four sets on Sunday to win the US Open as loud boos — mixed with a smattering of cheers — greeted President Donald Trump at the final in New York.

The 22-year-old Alcaraz won 6-2, 3-6, 6-1, 6-4 to capture his second US Open crown and sixth Grand Slam title, avenging his lone defeat in a major final by Sinner at Wimbledon in July.

Alcaraz will reclaim the world number one ranking from Sinner, returning to top spot for the first time since September 2023 after ending the Italian’s 27-match winning run at hard-court Grand Slams.

“I tried my best today. I couldn’t do more,” said Sinner, who was also defeated by Alcaraz in an epic French Open final in June.

Sinner’s defeat extends the longest drought without a successful men’s title defence of any Grand Slam in the Open era.

No man has retained the US Open crown since Roger Federer won five in a row from 2004 to 2008.

Anticipation for the third straight Grand Slam final between the sport’s top two players assumed an even greater dimension with the presence of Trump.

It was the latest in a series of visits to major sporting events for the US leader after his trip to the NFL’s Super Bowl in February and the FIFA Club World Cup final in July.

He appeared before the playing of the Star-Spangled Banner, waving to the crowd, which greeted him with a mix of cheers and boos. He was given a frostier reception later in the match though when shown again on the stadium’s big screens.

A constellation of showbiz and sports icons turned out as well, with rock star Bruce Springsteen, fashion icon Tommy Hilfiger, actor Michael Douglas and basketball superstar Stephen Curry all on hand.

– Start delayed by Trump visit –

The start of the final was pushed back 30 minutes to allow fans additional time to enter Arthur Ashe Stadium as a result of tighter security measures in effect due to Trump’s attendance.

Even then the 23,000-capacity venue was no more than three-quarters full when Alcaraz broke Sinner in the opening game of the match.

As he did in the Wimbledon final, Alcaraz pinned Sinner on the back front early and broke a second time for a 5-2 lead before serving out to love.

With hundreds of spectators still waiting to get in at the start of the second set, Alcaraz sought to hammer home his advantage.

He created a break point but Sinner hung on and stalled Alcaraz’s momentum, belatedly ramping up his game and surging 3-1 ahead as the Spaniard suffered a brief dip on serve.

Sinner levelled the contest at a set apiece but Alcaraz stormed back with another break early in the third, wriggling out of a tight spot on serve with the help of a sensational baseline smash that sliced away from his rival for a 3-0 edge.

He padded his lead with another break and quickly wrapped up the set, keeping his foot down to corner Sinner again to begin the fourth set.

This time Sinner saved two break points but Alcaraz made another charge in the fifth game, delivering the decisive blow for an advantage he never relinquished as the Spaniard became only the fourth man to win multiple majors on hard court, grass and clay.

Vanguard News
The post Alcaraz beats Sinner to win US Open, reclaims No.1 ranking appeared first on Vanguard News.

By admin

You missed

From Tramadol to Canadian to Exol-5 The New Drug Destroying Nigerian Youths An Investigative Article .From Tramadol to Canadian to Exol-5: The New Drug Destroying Nigerian Youths An Investigative Report on the Shifting Landscape of Substance Abuse in Nigeria Nigeria faces a severe and evolving drug crisis, particularly among its youth. What began with the widespread abuse of Tramadol has progressed through mixtures like “Canadian” to newer pharmaceutical diversions such as Exol-5. This shift reflects deeper issues: easy access to prescription drugs, weak regulation, socioeconomic pressures, and aggressive street-level marketing. NDLEA operations and health studies reveal a public health emergency that threatens an entire generation. Phase 1: The Tramadol Epidemic (2010s–Early 2020s) Tramadol, a synthetic opioid prescribed for moderate to severe pain, became Nigeria’s most notorious street drug. Cheap, potent, and widely smuggled (often from India and other Asian countries), it offered users energy, euphoria, and pain relief — appealing to commercial drivers, laborers, students, and young men seeking confidence or stamina. Scale of the Problem: Millions of tablets seized annually by NDLEA. High prevalence among young males aged 15–35. Linked to increased crime, sexual violence, organ damage (kidney failure, seizures), and mental health breakdowns. Contributed to broader opioid misuse alongside codeine cough syrups. Government responses included tighter import controls and public awareness campaigns, but these only displaced demand to other substances rather than eliminating it. Phase 2: The Rise of “Canadian” (Mid-2020s) “Canadian” or “Canadian Loud” emerged as a popular code for high-grade cannabis (often indica-dominant strains) or cannabis mixed with other synthetics. It gained traction as users sought alternatives or combinations to Tramadol’s effects. This phase marked a move toward imported or locally cultivated premium weed, sometimes laced with stronger chemicals. Youths in urban centers like Lagos, Kano, Jos, and Onitsha embraced it for its perceived “cleaner” high compared to opioids. However, it fueled polydrug use — combining cannabis with opioids, sedatives, or alcohol — amplifying health risks. Phase 3: Exol-5 – The Current Threat (2024–2026) Exol-5 (Benzhexol Hydrochloride / Trihexyphenidyl 5mg), originally a prescription medication for Parkinson’s disease and drug-induced movement disorders, has become the latest pharmaceutical being heavily abused. Why Exol-5? Euphoric Effects: Users report intense euphoria, hallucinations, and a sense of detachment — making it attractive as a cheap “upper” or escape. Accessibility: Sold over-the-counter or on the black market despite being a controlled prescription drug. NDLEA has seized millions of pills in single operations (e.g., 3.1 million pills in Kano in late 2024, and over 5.6 million combined with Tramadol in other busts). Street Names: Exol, Artane, Benzhexol, “Farin Mallam” (in Northern Nigeria). Demographics: Prevalent among youths, laborers, and even psychiatric patients who divert prescriptions. Studies show abuse rates as high as 25% among certain outpatient groups. Health Consequences: Anticholinergic toxicity: Confusion, dry mouth, blurred vision, urinary retention, constipation, and in high doses — delirium, psychosis, seizures, and heart issues. Long-term: Cognitive impairment, addiction, exacerbated mental health disorders. Often mixed with Tramadol, codeine, or cannabis, creating dangerous synergies. In cities like Jos, Exol-5 sits alongside diazepam, Rohypnol, and Tramadol on street markets, easily available to teenagers and young adults. Why This Evolution Continues Supply-Side Failures: Porous borders, corrupt officials, and overproduction of pharmaceuticals enable diversion. Demand Drivers: Unemployment, poverty, peer pressure, trauma, and the pursuit of performance enhancement (e.g., for “hustle” culture). Weak Regulation: Many pharmacies sell restricted drugs without prescriptions. Online and street vendors fill gaps. Displacement Effect: Cracking down on one substance (Tramadol/codeine) pushes users and dealers toward the next available option. NDLEA reports ongoing large seizures, but the problem persists due to high profitability and low risk for mid-level distributors. Broader Impacts on Nigerian Youths Education: Increased dropout rates and poor academic performance. Mental Health: Rising cases of psychosis and depression. Economy: Lost productivity among the working-age population. Crime and Violence: Drug-fueled robberies, cultism, and family breakdowns. Public Health System Strain: Overburdened hospitals treating overdoses and chronic complications. Young people aged 15–39 remain the hardest hit, with national surveys showing drug use prevalence significantly above global averages. What Must Be Done Stronger Enforcement: Consistent prosecution of corrupt enablers and large-scale traffickers. Regulation: Crackdown on rogue pharmacies and better tracking of prescription drugs. Prevention & Rehabilitation: School programs, community outreach, and expanded treatment centers (currently woefully inadequate). Economic Alternatives: Address root causes like youth unemployment. Public Awareness: Honest campaigns highlighting real dangers of “Exol-5” and similar drugs. Conclusion From Tramadol’s opioid grip to “Canadian” cannabis culture and now Exol-5’s anticholinergic highs, Nigeria’s drug crisis is mutating faster than responses can contain it. Exol-5 represents the dangerous new frontier — a legitimate medicine turned youth destroyer due to misuse and greed. Without urgent, multi-layered intervention — combining supply disruption, demand reduction, and socioeconomic support — an entire generation risks being lost to addiction. The time for half-measures is over. Nigeria’s future depends on winning this fight.